Large-scale testing (Phase 3)Study completedNCT00150202What this trial is testingClinical Study Of EYE001 For Wet-Type AMD (Age-Related Macular Degeneration)Who this might be right forMacular Degeneration Pfizer 90
Testing effectiveness (Phase 2)Study completedNCT00284089What this trial is testingSafety and Efficacy of Ranibizumab in Japanese Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular DegenerationWho this might be right forSubfoveal Choroidal Neovascularization(CNV) Secondary to Age-related Macular Degeneration (AMD) Novartis 88
Large-scale testing (Phase 3)Looking for participantsNCT07064759What this trial is testingSingle Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular DegenerationWho this might be right forNeovascular Age-Related Macular Degeneration (nAMD) 4D Molecular Therapeutics 480
Large-scale testing (Phase 3)Active Not RecruitingNCT06864988What this trial is testing4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular DegenerationWho this might be right forMacular Neovascularization Secondary to Age-Related Macular Degeneration 4D Molecular Therapeutics 480
Large-scale testing (Phase 3)Ended earlyNCT04049266What this trial is testingEvaluate the Efficacy and Safety of KSI-301, an Anti-VEGF Antibody Biopolymer Conjugate, Versus Aflibercept in Patients With Neovascular (Wet) Age-Related Macular Degeneration.Who this might be right forWet Macular Degeneration Kodiak Sciences Inc 559
Testing effectiveness (Phase 2)Study completedNCT01016873What this trial is testingINTREPID - IRay Plus Anti-VEGF Treatment For Patients With Wet AMDWho this might be right forAMDWet AMDAge-Related Macular Degeneration+4 more Oraya Therapeutics, Inc. 230
Large-scale testing (Phase 3)Study completedNCT00251459What this trial is testingEvaluate Ranibizumab in Subjects With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)Who this might be right forChoroidal NeovascularizationAge-related Macular Degeneration Genentech, Inc. 5,000
Large-scale testing (Phase 3)Study completedNCT03844074What this trial is testingA Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)Who this might be right forAge-related Macular DegenerationNeovascular Age-related Macular DegenerationWet Macular Degeneration Outlook Therapeutics, Inc. 61
Large-scale testing (Phase 3)Study completedNCT04005352What this trial is testingStudy to Assess the Efficacy and Safety of Brolucizumab 6mg Compared to Aflibercept 2 mg in a Treat-to-control Regimen (TALON)Who this might be right forAge-related Macular Degeneration Novartis Pharmaceuticals 734
Large-scale testing (Phase 3)Study completedNCT01436864What this trial is testingA Randomized, Double-masked, Multicenter,Sham-controlled, Safety and Efficacy Study of KH902 in Patients With Wet AMDWho this might be right forNeovascular Age-related Macular Degeneration Chengdu Kanghong Biotech Co., Ltd. 125
Testing effectiveness (Phase 2)Study completedNCT01162746What this trial is testingComparison of Ranibizumab Monotherapy and Ranibizumab Combination Therapies in Recurrent or Persistent Choroidal Neovascularization Secondary to Age-related Macular DegenerationWho this might be right forAge-Related Macular DegenerationNeovascularization, Choroidal Medical University of Vienna 40
Large-scale testing (Phase 3)Study completedNCT04964089What this trial is testingEvaluate the Efficacy and Safety of Intravitreal KSI-301 Compared With Intravitreal Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD)Who this might be right forWet Age-related Macular Degeneration Kodiak Sciences Inc 557
Not applicableStudy completedNCT00845273What this trial is testingLong-Term Use Of Pegaptanib In Patients For Subfoveal Choroidal Neovascularization Secondary To Age-Related Macular DegenerationWho this might be right forMacular Degeneration Pfizer 3,538
Large-scale testing (Phase 3)Study completedNCT03823300What this trial is testingEvaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (LUCERNE)Who this might be right forWet Macular Degeneration Hoffmann-La Roche 658
Large-scale testing (Phase 3)Study completedNCT00429962What this trial is testingStudy Comparing Ranibizumab Monotherapy With Combined Verteporfin Therapy in Subfoveal CNVWho this might be right forChoroidal NeovascularizationAge-Related Macular Degeneration University Hospital, Basel, Switzerland 40
Testing effectiveness (Phase 2)Study completedNCT01414153What this trial is testingEfficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMDWho this might be right forExudative Age-related Macular Degeneration Lpath, Inc. 158
Large-scale testing (Phase 3)Study completedNCT00826371What this trial is testingEvaluation of Safety and Efficacy of Once Monthly Ranibizumab Injections in Chinese Patients With Wet Age Related Macular Degeneration (AMD) PatientsWho this might be right forAge Related Macular Degeneration Novartis Pharmaceuticals 114
Large-scale testing (Phase 3)Study completedNCT03834753What this trial is testingA Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)Who this might be right forAge-related Macular DegenerationNeovascular Age-related Macular DegenerationWet Macular Degeneration Outlook Therapeutics, Inc. 228
Early research (Phase 1)Ended earlyNCT01334255What this trial is testingISONEP to Treat Persistent Pigment Epithelial Detachment (PED) in Subjects With Exudative Age-Related Macular Degeneration (AMD) or Polypoidal Choroidal Vasculopathy (PCV)Who this might be right forPigment Epithelial Detachment Lpath, Inc. 12
Large-scale testing (Phase 3)Study completedNCT00436553What this trial is testingEfficacy/Safety of Verteporfin Photodynamic Therapy and Ranibizumab Compared With Ranibizumab in Patients With Subfoveal Choroidal NeovascularizationWho this might be right forMacular DegenerationChoroidal Neovascularization Novartis 321